GLP-1 Drugs Linked to Lower Depression and Anxiety Risk in Large Long-Term Study
A decade-long study of nearly 100,000 people found that GLP-1 receptor agonist drugs like semaglutide (Ozempic/Wegovy) were associated with significantly reduced psychiatric hospital visits and fewer sick days. While the mechanism remains unclear, these findings suggest potential mental health benefits alongside the known metabolic effects of these medications.

